CAPTURA BIOPHARMA
Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide contamination and heavy metal poisoning. Its lead chelation candidate, C2E2, will be the world's first oral treatment indicated for internal radiation contamination and has been proven in efficacy studies to target select heavy metals, notably americium, plutonium, and lead. Heavy metal contamination, including exposure to transuranic elements, is on the rise.
CAPTURA BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Address:
Little Rock, Arkansas, United States
Country:
United States
Website Url:
http://www.capturabiopharma.com
Total Employee:
1+
Status:
Active
Contact:
501-516-3905
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Current Employees Featured
Founder
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Venture Round - Captura Biopharma
Official Site Inspections
http://www.capturabiopharma.com
- Host name: 255.209.73.34.bc.googleusercontent.com
- IP address: 34.73.209.255
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York

More informations about "Captura Biopharma"
Captura Biopharma - A Solution to Capturing Radioactive Heavy โฆ
Captura Biopharma is developing an oral solution that can immediately be administered to eliminate harmful radioactive material from the body.See details»
Captura Biopharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 501-516-3905 Captura Biopharma is an biotechnology company engaged in the development and commercialization โฆSee details»
About - Captura Biopharma
Captura Biopharma was founded by Michael Geranen and Anthony Soscia based on research performed at the University of North Carolina. Captura is located in Little Rock, AR and itโs lead product, C2E2, has been funded by grants from โฆSee details»
Captura Biopharma Company Profile | Management and โฆ
Www.capturabiopharma.com . Captura Biopharma Profile and History. Captura Biopharma is developing an oral solution that can immediately be administered to eliminate harmful โฆSee details»
Captura Biopharma, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Captura Biopharma, Inc. of Little Rock, AR. Get the latest business insights from Dun & Bradstreet.See details»
Captura Biopharma - PitchBook
Captura Biopharma General Information Description. Operator of a biotechnology company engaged in the development of IV chelation drugs. The company offers drugs for the treatment โฆSee details»
Captura Biopharma - LinkedIn
Captura Biopharma Pharmaceutical Manufacturing Little Rock, Arkansas 191 followers Captura Biopharma: Our Solution is THE Solution!See details»
The Captura Team - Captura Biopharma
Dr. Gary Barnette Ph.D., Regulatory. Dr. Barnette was Sr. Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services, LLC from 2012 to August 2018 and โฆSee details»
Captura Biopharma, Inc. in Little Rock, AR - (501) 516-3905 - Profile
Captura Biopharma, Inc. is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Captura Biopharma - Crustdata Company Profile, Funding and โฆ
Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide โฆSee details»
Captura Biopharma - Company Profile - Tracxn
Feb 8, 2025 Captura Biopharma - Developer of therapeutic to eliminate harmful radioactive material from the body. Acquired by OceanTech Acquisitions. Raised funding over 1 round โฆSee details»
Captura Biopharma - Overview, News & Similar companies
Www.capturabiopharma.com. Revenue <$5 Million. Industry Drug Manufacturing & Research Pharmaceuticals Healthcare . Recent News & Media. OceanTech Acquisitions I Corp. โฆSee details»
Captura Biopharma - Products, Competitors, Financials, Employees ...
Captura Biopharma is a biotechnology company developing an oral solution that can immediately be administered to eliminate harmful radioactive material from the body. Use the CB Insights โฆSee details»
Captura Biopharma LLC - discovery.patsnap.com
Captura Biopharma is a company that provides Biology, Biotechnology and more. Captura Biopharma is headquartered in United States Arkansas. Captura Biopharma was founded in โฆSee details»
Background - Captura Biopharma
Captura Biopharmaโs proposed product, C2E2, is a diethyl ester of DTPA, which has been shown to be orally bioavailable and to chelate the transuranic radionuclide americium (241Am) in โฆSee details»
Captura Biopharma Secures $50 Million Investment Commitment โฆ
Aug 18, 2021 Captura Biopharma Secures $50 Million Investment Commitment from GEM as Company Seeks to Go Public in Coming Months The Company plans to go public in the โฆSee details»
Captura Biopharma Secures $50 Million Investment ... - Markets โฆ
Aug 18, 2021 Contact: [email protected] . Press Contact: Steve Smith 501-547-7502 View original content: ...See details»
Project Status - Captura Biopharma
IND-enabling tasks have been completed for C2E2, Captureโs lead development candidate, including pre-formulation characterization of the drug molecule, extensive safety-toxicology โฆSee details»
Captura BioPharma - Matmon Internet Inc.
The Captura Biopharma website needs to convey a lot of information, and the old site lacked organization and readability. The new design reorders information into digestible facts and โฆSee details»
The Solution - Captura Biopharma
Ca-DTPA (trisodium calcium diethylenetriaminepentaacetate) and Zn-DTPA (trisodium zinc diethylenetriaminepentaacetate) have been used extensively for over forty years as โฆSee details»